Simple Summary Glioblastoma is a highly aggressive brain cancer, and early detection and
accurate diagnosis are crucial for effective treatment. Traditional diagnostic methods have …

Glioblastoma (GB) is a rare but extremely aggressive brain tumor that significantly impacts
patient outcomes, affecting both duration and quality of life. The protocol established by …

Glioblastoma is the most aggressive brain tumour with short survival, partly due to resistance
to conventional therapy. Glioma stem cells (GSC) are likely to be involved in treatment …

Glioblastoma multiforme (GBM) is a malignancy of bad prognosis, and advances in early
detection and treatment are needed. GBM is heterogenous, with varieties differing in …

A growing body of experimental and clinical evidence suggests that rare cell populations,
known as cancer stem cells (CSCs), play an important role in the development and …

Despite the great progress over the past few decades in both the diagnosis and treatment of
a great variety of human cancers, glioblastoma remains the most lethal brain tumor. In recent …

The highly aggressive and invasive glioblastoma (GBM) tumour is the most malignant lesion
among adult-type diffuse gliomas, representing the most common primary brain tumour in …

Muscle Invasive Bladder Cancer (MIBC) is a subset of bladder cancer with a significant risk
for metastases and death. It accounts for nearly 25% of bladder cancer diagnoses. A …

With a reported rise in global air pollution, more than 50% of the population remains
exposed to toxic air pollutants in the form of particulate matters (PMs). PMs, from various …

Like most tumors, glioblastoma multiforme (GBM), the deadliest brain tumor in human
adulthood, releases extracellular vesicles (EVs). Their content, reflecting that of the tumor of …